Literature DB >> 8491525

Prevalence of hyperimmunization against tetanus in Italians born after the introduction of mandatory vaccination of children with tetanus toxoid in 1968.

G Gentili1, R D'Amelio, M Wirz, P M Matricardi, R Nisini, C Collotti, P Pasquini, T Stroffolini.   

Abstract

Systematic mandatory immunization of children against tetanus was started in Italy in 1968. Prevalence of tetanus hyperimmunization (> 5 IU/ml) was assessed among 214 immune subjects born after 1968 and found to be 17.3%. This figure is significantly higher (p < 0.01) than the 10.8% found in a previous study of subjects born before 1968. This increase is statistically significant in the Center (p < 0.01) and in the South (p < 0.05) of Italy, but not in the North. Hyperimmunization is not associated with family size (odds ratio 2.16; C. I. 95% = 0.5-7.6) or the father's years of education (odds ratio 1.83; C. I. 95% = 0.6-5.3). No difference was found between urban and rural areas of residence. Indiscriminate administration of booster doses of tetanus vaccine in hyperimmune subjects in some areas could result in unnecessary vaccinations, which can cause hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491525     DOI: 10.1007/BF01710736

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Tetanus immunity in a partially vaccinated population of children in a district of Naples (Secondigliano).

Authors:  P D'Argenio; M Wirz; F Rosmini; B Adamo; G Gentili; M Puccinelli; C Collotti; A Mele; D Esposito; P Forte
Journal:  Eur J Epidemiol       Date:  1992-01       Impact factor: 8.082

2.  Prevalence of hyperimmunization against tetanus in a national sample of 18-26 year old immune subjects in Italy.

Authors:  M Wirz; G Gentili; F Rosmini; C Collotti; A Paná; I Terzi; S Conti; P Pasquini
Journal:  Vaccine       Date:  1987-09       Impact factor: 3.641

3.  Total and IgE antibody levels following booster immunization with aluminum absorbed and nonabsorbed tetanus toxoid in humans.

Authors:  M Cogné; J J Ballet; C Schmitt; B Bizzini
Journal:  Ann Allergy       Date:  1985-02

4.  Adverse reactions to tetanus toxoid.

Authors:  R L Jacobs; R S Lowe; B Q Lanier
Journal:  JAMA       Date:  1982-01-01       Impact factor: 56.272

5.  [Obligatory anti-tetanus vaccination and the public health service].

Authors:  F Di Stanislao; F Bordicchia; P Strusi; G Renga
Journal:  Boll Ist Sieroter Milan       Date:  1985

6.  [Persistence of antibody levels for 5, 10 or more years after tetanus vaccination and immunological response to a "booster" immunization].

Authors:  A Simonetti D'Arca; N Vescia; I Mastroeni; G Melino; G Bellante
Journal:  Boll Ist Sieroter Milan       Date:  1980-11-30

7.  Booster immunisation for diphtheria and tetanus: no evidence of need in adults.

Authors:  R G Mathias; M T Schechter
Journal:  Lancet       Date:  1985-05-11       Impact factor: 79.321

8.  Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination.

Authors:  O Simonsen; K Kjeldsen; I Heron
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

9.  The use of an immunoenzymatic assay for the estimation of tetanus antitoxin in human sera: a comparison with seroneutralization and indirect haemagglutination.

Authors:  G Gentili; C Pini; C Collotti
Journal:  J Biol Stand       Date:  1985-01
  9 in total
  3 in total

Review 1.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

2.  Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy.

Authors:  Pauline Versteegen; Axel A Bonačić Marinović; Pieter G M van Gageldonk; Saskia van der Lee; Lotte H Hendrikx; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Vaccines (Basel)       Date:  2022-04-28

3.  Causality assessment of adverse events following immunization: the problem of multifactorial pathology.

Authors:  Paolo Bellavite
Journal:  F1000Res       Date:  2020-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.